Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-04-18
2008-03-18
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S279000
Reexamination Certificate
active
07345040
ABSTRACT:
Reverse-turn mimetics and methods relating to the same having the following structure are disclosed:including pharmaceutically acceptable salts and stereoisomers thereof, wherein R1, R2, R3and R4are as defined herein. Such compounds have utility over a wide range of applications, including use as diagnostic and therapeutic agents. In particular, compounds of this invention, and pharmaceutical compositions containing such compounds, are neurokinin (tachykinin) antagonists. Libraries containing the reverse-turn mimetics of this invention are also disclosed.
REFERENCES:
patent: 5440013 (1995-08-01), Kahn
patent: 5545568 (1996-08-01), Ellman
patent: 5929237 (1999-07-01), Kahn
patent: 6013458 (2000-01-01), Kahn et al.
patent: 6184223 (2001-02-01), Kahn et al.
patent: 6413963 (2002-07-01), Kahn et al.
patent: 6548500 (2003-04-01), Kahn et al.
patent: WO 1992/13878 (1992-08-01), None
patent: WO 1994/03494 (1994-02-01), None
patent: WO 1996/22304 (1996-07-01), None
patent: WO 1996/30396 (1996-10-01), None
patent: WO 1997/15557 (1997-05-01), None
patent: WO 1997/15577 (1997-05-01), None
patent: WO 1998/05333 (1998-02-01), None
patent: WO 1998/49168 (1998-11-01), None
patent: WO 2004/066947 (2004-08-01), None
Abignente et al., “Research on heterocyclic compounds. XVI. 2-Methylimidazo[1,2-a]pyrazine-3-carboxylic acids”,Chemical Abstracts Database, 1985, Accession No. 103:87841.
Antonov et al., “Activation of the Amide Grouping by Acylation”,Journal of General Chemistry of the USSR, Oct. 1967, 37(10):2112-2120.
Barrow et al., “Spiroquinazoline, a novel substance P inhibitor with a new carbon skeleton, isolated fromAspergillus flavipes”, Chemical Abstracts Database, 1994, Accession No. 121:129499.
Cutler et al., “Cinereain: a novel metabolite with plant growth regulating properties fromBotrytis cinerea”, Chemical Abstracts Database, 1988, Accession No. 109:165645.
Dennin et al., “Synthesis of derivatives of pyrazino[1,2-a]pyrimidin-4-ones”,Chemical Abstracts Database, 1991, Accession No. 114:164135.
Faehnle et al., “Syntheses and reactions of peptide cyclols”,Chemical Abstracts Database, 1985, Accession No. 102:7061.
Gatta et al., “New [f]-fused xanthines: synthesis of 1,3-dipropyl-1H-pyrazino, pyrido, pyrimido and pyrrolo [2,1-f]purine-2,4-diones”,Chemical Abstracts Database, 1994, Accession No. 121:57444.
Jackson et al., “Potent α4β1 Peptide Antagonists as Potential Anti-Inflammatory Agents”,J. Med. Chem., Mar. 17, 1997, 40(21):3359-3368.
Kadam et al., “Fermentative manufacture of multiple drug resistance-attenuating ardeemins”,Chemical Abstracts Databse, 1994, Accession No. 121:407435.
Kappe et al., “Cross-conjugated and pseudo-cross-conjugated mesomeric betaines. XVIII. Bicyclic mesoionic pyrimidines with cardiovascular activity”,Chemical Abstracts Database, 1992, Accession No. 116:83634.
Ku et al., “Direct Design of a Potent Non-Peptide Fibrinogen Receptor Antagonist Based on the Structure and Conformation of a Highly Constrained Cyclic RGD Peptide”,J. Am. Chem. Soc., May 28, 1993, 115(19):8861-8862.
Lam et al., “A new type of synthetic peptide library for identifying ligand-binding activity”,Nature, Nov. 7, 1991, 354:82-84.
Lucente et al., “Cyclization of Activated N-Benzyloxycarbonyl-tripeptides”,Tetrahedron Letters, 1978, 11:1009-1012.
Lucente et al., “Synthesis and x-ray crystal structure of a tripeptidic cyclol”,Chemical Abstracts Database, 1982, Accession No. 96:69410.
Numata et al., “Structures of cytotoxic substances and new quinazoline derivatives produced by a fungus from a saltwater fish”,Chemical Abstracts Database, 1992, Accession No. 116:210833
Okawara et al., “Preparation and hydrogenolysis of fused piperazines by reaction of diamine and triamine derivatives with benzil. Application to the synthesis of terminal N-monoprotected triamines”,Chemical Abstracts Database, 1992, Accession No. 117:191810.
Okawara et al., “Simple preparation of terminal N-monoprotected triamines using fused piperazines”,Chemical Abstracts Database, 1991, Accession No. 114:101300.
Penn et al., “Biosynthesis of glyantrypine byAspergillus clavatus,” Chemical Abstracts Database, Accession No. 117:44249, 1992.
Penn et al., “Glyantrypine, a novel anthranilic acid-containing metabolite ofAspergillus clavatus”, Chemical Abstracts Database, 1992, Accession No. 117:127875.
Pillay et al., “Molecular Mechanisms, Emerging Etiological Insights and Models to Test Potential Therapeutic Interventions in Alzheimer's Disease”,Current Alzheimer Research, 2004, 1(4):295-306.
Pinnen et al., “Cyclization under mild conditions of anthraniloyl and N-methylanthraniloyl dipeptides”,Chemical Abstracts Database, 1989, Accession No. 110:76029.
Pinnen et al., “Ten-membered cyclotripeptides: influence of the ring-flexibility on intramolecular reactions”,Chemical Abstracts Database, 1985, Accession No. 102:132448.
Portegies et al., “AIDS Dementia Complex, Diagnosis and Drug Treatment Options”,CNS Drugs, Jan. 1998, 9(1):31-40.
Rothe et al., “Cyclol formation during tripeptide cyclizations. Synthesis of a secondary cyclotripeptide, cyclo-(D-Phe-L-Pro-L-Pro)”,Chemical Abstracts Database, 1982, Accession No. 97:56231.
Rothe et al., “Secondary all-L-cyclotripeptides”,Chemical Abstracts Database, 1985, Accession No. 103:215766.
Sauter et al., “Novel basically substituted pyrimidines and benzothienopyrimidines”,Chemical Abstracts Database, 1977, Accession No. 87:84931.
Souers et al., “Novel Inhibitors of α4β1 Integrin Receptor Interactions through Library Synthesis and Screening”,Bioorganic&Medicinal Chemistry Letters, 1998, 8:2297-2302.
Tanaka et al., “Syntheses of pyrido[2,3-b]pyrazine derivaties”,Chemical Abstracts Database, 1976, Accesson No. 84:31002.
The Merck Manual, Fifteenth Edition, 1987, pp. 1069-1083.
Huang Danwen
Little Thomas
Mathew Jessymol
Qabar Maher N.
Stasiak Marcin
Jaisle Cecilia M
Ley, III Herbert L.
Myriad Genetics Inc.
Myriad IP Dept.
Wilson James O.
LandOfFree
Reverse-turn mimetics and compositions and methods relating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reverse-turn mimetics and compositions and methods relating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reverse-turn mimetics and compositions and methods relating... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3971538